COLUCID PHARMACEUTICALS INC's ticker is CLCD and the CUSIP is 19716T101. A total of 1 filers reported holding COLUCID PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $13,031,000 | -14.6% | 358,000 | -10.5% | 3.30% | +32.8% |
| Q3 2016 | $15,260,000 | +273.5% | 400,000 | -20.0% | 2.48% | +134.2% |
| Q2 2016 | $4,086,000 | +136.7% | 500,137 | +79.7% | 1.06% | +183.7% |
| Q1 2016 | $1,726,000 | -27.8% | 278,337 | -2.5% | 0.37% | +6.9% |
| Q4 2015 | $2,390,000 | +94.6% | 285,525 | -10.0% | 0.35% | +122.9% |
| Q3 2015 | $1,228,000 | -56.5% | 317,250 | 0.0% | 0.16% | -43.3% |
| Q2 2015 | $2,824,000 | – | 317,250 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 3,156,563 | $120,423,000 | 10.70% |
| BVF INC/IL | 763,300 | $29,120,000 | 5.49% |
| GREAT POINT PARTNERS LLC | 400,000 | $15,260,000 | 3.89% |
| VHCP Management II, LLC | 159,110 | $6,070,000 | 3.12% |
| Vivo Capital, LLC | 225,000 | $8,584,000 | 2.68% |
| VHCP Management, LLC | 68,190 | $2,601,000 | 2.56% |
| SPHERA FUNDS MANAGEMENT LTD. | 400,000 | $15,260,000 | 2.48% |
| NEXTHERA CAPITAL LP | 100,000 | $3,815,000 | 2.34% |
| AWM Investment Company, Inc. | 288,919 | $11,022,000 | 2.02% |
| Perceptive Advisors | 552,030 | $21,060,000 | 1.36% |